Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: Role of the A33R protein in antibody-resistant spread

Journal of General Virology

Volumn 83, Issue 1, 2002, Pages 209-222

  Law, M ^a   Hollinshead, R ^a   Smith, G L ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CLINICAL PATHWAY; CONTROLLED STUDY; GENE DELETION; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIROGENESIS; VIRUS ENVELOPE; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS PLAQUE;

ANIMALIA; DNA VIRUSES; VACCINIA VIRUS;

EID: 0036135030     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-1-209     Document Type: Article

References (74)

1. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection
2. Neutralizing activities of antisera to poxvirus soluble antigens
3. An antigenic difference between intracellular and extracellular rabbitpox virus
4. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein
5. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread
6. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: Effect of a point mutation in the lectin homology domain of the A34R gene
7. Morphogenesis and release of fowlpox virus
8. Differences between extracellular and intracellular forms of poxvirus and their implications
9. The nature of the immune state produced by inactivated vaccinia virus in rabbits
10. The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions
11. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells
12. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress
13. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence
14. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope
15. Measles virus spread by cell-cell contacts: Uncoupling of contact-mediated receptor (CD46) down-regulation from virus uptake
16. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression
17. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens
18. Functional analysis of vaccinia virus B5R protein: Essential role in virus envelopment is independent of a large portion of the extracellular domain
19. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment
20. Characterization of intracellular and extracellular vaccinia virus variants:
21. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen
22. Vaccinia virus utilizes microtubules for movement to the cell surface
23. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge
24. Extracellular enveloped vaccinia virus escapes neutralization
25. Biogenesis of poxviruses: Interrelationship between hemagglutinin production and polykaryocytosis
26. Adsorption and penetration of the trypsinized vaccinia virion
27. Neutralizing epitope on penetration protein of vaccinia virus
28. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope
29. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI
30. 2-3-methyl-4-chlorobenzoyl-hydrazine
31. Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV
32. Antibody neutralization of the extracellular enveloped form of vaccinia virus
33. Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon
34. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus
35. The immunogenicity of heat-inactivated vaccinia virus in rabbits
36. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation
37. A mutational analysis of the vaccinia virus B5R protein
38. Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells
39. Poxviridae: The viruses and their replication
40. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
41. r 43-50 K protein on the surface of extracellular enveloped virus
42. Polypeptide composition of extracellular enveloped vaccinia virus
43. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia
44. Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation
45. Adsorption and penetration of enveloped and naked vaccinia virus particles
46. 2-3-methyl-4-chlorobenzoylhydrazine
47. The downregulation of CD4 and MHC-1 by primate lentiviruses: A paradigm for the modulation of cell surface receptors
48. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene
49. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus
50. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation
51. Cell motility and morphology: Viruses in control
52. Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion
53. Virus-induced cell motility
54. The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles
55. Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans-Golgi network
56. r protein confers resistance to an inhibitor of virus envelopment and release
57. Nucleotide sequence of the vaccinia virus hemagglutinin gene
58. Biogenesis of vaccinia: Carbohydrate of the hemagglutinin molecules
59. Plaque morphology of herpes simplex virus in various cells under liquid overlay as a marker for its type differentiation
60. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes
61. Release of vaccinia virus from FL cells infected with the IHD-W strain
62. Inactivated smallpox vaccine: Immunogenicity of inactivated intracellular and extracellular vaccinia virus
63. Brefeldin A inhibits vaccinia virus envelopment but does not prevent normal processing and localization of the putative envelopment receptor P37
64. A novel virus binding assay using confocal microscopy: Demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors
65. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation
66. Intracellular and extracellular vaccinia virions enter cells by different mechanisms
67. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope
68. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles
69. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface
70. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera
71. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination
72. The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus
73. Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread
74. Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence